Form 8-K - Current report:
SEC Accession No. 0001193125-24-229255
Filing Date
2024-10-01
Accepted
2024-09-30 20:05:58
Documents
13
Period of Report
2024-09-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d892677d8k.htm   iXBRL 8-K 33915
  Complete submission text file 0001193125-24-229255.txt   156810

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grts-20240930.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20240930_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20240930_pre.xml EX-101.PRE 11263
15 EXTRACTED XBRL INSTANCE DOCUMENT d892677d8k_htm.xml XML 3634
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 241340961
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)